Invenomic Capital Management’s TD Synnex SNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-52,521
Closed -$6.16M 197
2024
Q4
$6.16M Sell
52,521
-131,637
-71% -$15.8M 0.29% 102
2024
Q3
$22.1M Sell
184,158
-35,703
-16% -$4.13M 1.22% 28
2024
Q2
$25.4M Sell
219,861
-10,762
-5% -$1.32M 1.23% 22
2024
Q1
$26.1M Buy
+230,623
New +$24M 1.39% 22
2022
Q4
Sell
-38,566
Closed -$3.13M 169
2022
Q3
$3.13M Buy
+38,566
New +$3.68M 0.27% 101

Other funds holding SNX

Invenomic Capital Management's SNX Position: Q1 2025 in Review

Invenomic Capital Management sold out of TD Synnex (SNX) in Q1 2025, closing a stake of 52,521 shares — an estimated $6.16M sold.

Invenomic Capital Management first reported a position in SNX in Q3 2022 and held it in 5 quarters. The position peaked at $26.1M in Q1 2024. 477 funds tracked by Wall St. Rank hold SNX as of Q1 2025.

  • Invenomic Capital Management reported no remaining TD Synnex position as of Q1 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 52,521 TD Synnex shares in Q1 2025, an estimated $6.16M.
  • Invenomic Capital Management first reported a position in TD Synnex in Q3 2022 and held it in 5 quarters.
  • Invenomic Capital Management's TD Synnex position peaked at $26.1M in Q1 2024.
  • 477 funds tracked by Wall St. Rank held TD Synnex as of Q1 2025.

Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.